Category Archives: U.S. Policy and Funding

Report shows 1 in 10 medicines in low-and middle income countries are substandard, falsified

By on .

Antibiotics and antimalarial drugs are most frequently reported as substandard and falsified to the World Health Organization’s Global Surveillance and Monitoring system for such medical products, according to a WHO report released this week. The report estimates that one in ten medical products in low- and middle-income countries either fail to meet quality standards or […]